Bottom line
RYHEX vs SCHLX: the short answer
RYHEX (Health Care Fund) and SCHLX (DWS Health and Wellness Fund) are both mutual funds.
But RYHEX is far broader, holding 135 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.
SCHLX is cheaper at 1.06% vs 1.64% — a difference of $58 a year per $10,000 invested.
RYHEX has a front-end sales load of up to 4.75%; the other does not.
Updated Nov 19, 2026
RYHEX vs SCHLX side by side
| RYHEX | SCHLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Guggenheim | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.64% | 1.06% |
| Annual cost per $10k | $164 | $106 |
| 10-yr cost on $10k (prospectus) | $2,374 | $1,294 |
| Max front load | 4.75% | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +8.7% | — |
| 5-yr return (annualized) | +3.9% | — |
| 10-yr return (annualized) | +7.1% | — |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $19.4M | $231.8M |
| Number of holdings | 135 | 65 |
| Portfolio turnover | 244% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
20 of RYHEX's top 25 holdings also appear in SCHLX's top 25.
| Holding | RYHEX | SCHLX |
|---|---|---|
| Eli Lilly & Company | 3.63% | 13.85% |
| Johnson & Johnson | 2.88% | 6.19% |
| Abbvie Inc | 2.52% | 4.90% |
| Unitedhealth Group Inc | 2.22% | 5.73% |
| Merck & Company Inc | 2.04% | 4.85% |
| Thermo Fisher Scientific Inc | 1.61% | 3.46% |
| Amgen Inc | 1.56% | 2.88% |
| Abbott Laboratories | 1.42% | 2.39% |
| Gilead Sciences Inc | 1.39% | 2.78% |
| Vertex Pharmaceuticals Inc | 1.34% | 2.45% |
| Intuitive Surgical Inc | 1.31% | 2.69% |
| Danaher Corp | 1.30% | 2.13% |
| Pfizer Inc | 1.25% | 1.17% |
| Bristol-myers Squibb Company | 1.22% | 1.50% |
| Stryker Corp | 1.21% | 2.61% |
Source: SEC Form N-PORT
RYHEX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between RYHEX and SCHLX?
Which is cheaper, RYHEX or SCHLX?
Should I own both RYHEX and SCHLX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.